Clinical Trial Update: Neonatal Intensive Care (NICU) Course and Hospital Outcome of Infants With BPD Treated Using Inhaled Nitric Oxide

View source ↗

Summary

This completed clinical trial evaluated the NICU course and hospital outcomes of infants with bronchopulmonary dysplasia treated with inhaled nitric oxide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: University of Utah | Conditions: Bronchopulmonary Dysplasia | Status: COMPLETED